加入購物車SPECIFICATIONS
Product name Recombinant Human SAA1
- Source E.coli derived
- Accession # AAH07022.1
- SDS-PAGE 14 KDa, reducing conditions.
- N-terminal Sequence Arg
- Predicted Molecular Mass 13.2 kDa
- Activity Measured by its ability to combine Human SAA1 Antibody.
- Endotoxin Level /
- Application ELISA, standards, quality controls, others unspecified.
- Form Liquid
- Formulation Lyophilized from a 0.2 μm filtered solution of 20mM Tris, 150mM NaCl, pH 7.4
- Stability & Storage Lyophilized protein should be stored at < -20°C, though stable at room temperature for 3 weeks. Reconstituted protein solution can be stored at 4-7°C for 2-7 days.Aliquots of reconstituted samples are stable at < -20°C for 3 months.
- Shipping condition The product is shipped with dry ice or equivalent. Upon receipt, store it immediately at the temperature recommended front.
- Lot number 20231108
- Concentration /
- Conc. Determined BCA
- Purity >90%
Serum Amyloid A1 Protein (SAA1) is an acute phase apolipoprotein reactant that is produced predominantly by hepatocytes and is under the regulation of inflammatory cytokines. SAA is produced mainly in the liver and circulates in low levels in the blood. SAA may play a role in the immune system and facilitate the repair of injured tissues, it also acts as an antibacterial agent, and signals the migration of germ-fighting cells to sites of infection. SAA also functions as an apolipoprotein of the HDL complex. The SAA cleavage product designated amyloid protein A is deposited systemically as amyloid in vital organs such as the liver, spleen, and kidneys in chronic inflammatory diseases patients. These deposits are extremely insoluble and resistant to proteolysis; they disrupt tissue structure and compromise performance.
相似產(chǎn)品
13632887203